Skip to main content
. 2018 Apr 4;52(6):1886–1898. doi: 10.3892/ijo.2018.4356

Figure 3.

Figure 3

Increased LTBP2 expression is associated with poor overall survival of patients with GC. (A) Kaplan-Meier estimator analysis of 174 patients with GC indicating decreased overall survival time of patients with LTBP2high GC. (B) Kaplan-Meier estimator survival curve for overall survival of 875 patients with GC from the NCBI GEO database generated using the KM Plotter database. (C) Kaplan-Meier estimator survival curve for overall survival of 380 surgical patients with GC from the NCBI GEO database generated using the KM Plotter database. (D) Kaplan-Meier estimator analyses of overall survival of patients with GC in early-stage (TNM stage I/II) and late-stage (TNM stage III/IV) GC according to LTBP2 expression. (E) Kaplan-Meier estimator analyses of overall survival rate of patients with GC at TNM stage I (F) II, (G) III and (H) IV stage generated using KM Plotter database. LTBP2, latent transforming growth factor-β-binding protein 2; GC, gastric cancer; NCBI, National Center for Biotechnology Information; GEO, Gene Expression Omnibus; TNM, tumor-node-metastasis.